TABLE 4.

HPV Clearance After Completed Treatment

	Imiquimod Group (n=35)*	LLETZ Group (n=49)†	P
hrHPV clearance	24 (69%)	33 (67%)	0.91
HPV 16/18 clearance	9/15 (60%)	18/29 (62%)	0.89

^*Included were women who were positive for hrHPV at baseline, completed imiquimod treatment and underwent colposcopy with biopsies at 20 weeks follow-up. Twenty-six women were excluded from the analysis: 13 women stopped treatment, 4 underwent LLETZ at 10 weeks, 1 was lost to follow-up, 3 HPV-tests failed, and 5 others were negative at baseline.

^†Included were women who were positive for hrHPV at baseline. Thirteen women were excluded from the analysis: 12 were HPV negative at baseline and 1 was lost to follow-up.

HPV indicates human papillomavirus; hrHPV, high-risk human papillomavirus; LLETZ, large loop excision of the transformation zone.